Scientists have identified a cellular factor that could explain why dendritic cells, true “sentinel” of the immune system, sometimes have a poor response to the HIV virus, this discovery paving the way for the development…
IRX Therapeutics, a developer of immune therapies to make cancer treatments better, announced today it has signed a research collaboration agreement with one of the world’s leading research-based pharmaceutical companies. In this collaboration, tumor specimens…
An analysis of immune markers measured in a sub-study of ViroStatics’ proof-of-concept Phase 2a trial showed that VS411 was able to reduce immune activation while producing a median 1.5 log10 reduction in viral load. VS411…
The defense mechanisms may play a vital role in ensuring the prosperity of certain kinds of cancer therapies, according to new research by researchers in the Stanford University School of drugs. The study showed treatments…
Unchecked, the natural or innate immune system can exhaust control – like a stuck accelerator on a car. Eventually, it will kill the host it should really protect. That is important because the innate immune…
A study published in the diary Science offers a long-awaited explanation for that link between HIV infection and susceptibility to life-threatening nontyphoidal strains of Salmonella. The research, funded by the Wellcome Trust and GlaxoSmithKline, procedes…
Using T cells primed for the infectious disease toxoplasmosis, Whitehead Institute researchers have created novel mouse models of the immune system that more accurately reflect how immune cells actually respond to pathogens in their presence.…
A researcher from Northwestern University Feinberg School of Medicine has invented a novel way to halt and even reverse rheumatoid arthritis. He developed an imitation of a suicide molecule that floats undetected into overactive immune…